Federal Circuit: Abbott Did Not Infringe Novartis Patent For Human Transplant Drug
The Court of Appeals for the Federal Circuit has upheld a lower court's ruling that Abbott Laboratories did not infringe a Novartis patent for the human transplant drug cyclosporine....To view the full article, register now.
Already a subscriber? Click here to view full article